- SEK38.92bn
- SEK90.96bn
- SEK7.47bn
- 47
- 41
- 86
- 62
Annual balance sheet for Pandox AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,593 | 1,630 | 769 | 1,286 | 1,186 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 487 | 1,448 | 1,278 | 1,535 | 1,147 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,745 | 3,680 | 2,329 | 3,038 | 18,021 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,620 | 3,901 | 3,428 | 3,678 | 4,427 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 66,801 | 75,217 | 73,208 | 80,688 | 111,894 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6,572 | 17,512 | 10,649 | 4,662 | 20,474 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 41,588 | 44,486 | 43,635 | 47,160 | 78,165 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 25,213 | 30,731 | 29,573 | 33,528 | 33,729 |
| Total Liabilities & Shareholders' Equity | 66,801 | 75,217 | 73,208 | 80,688 | 111,894 |
| Total Common Shares Outstanding |